QT and Action Potential Duration

Overview

Journal Br Heart J

Specialty Cardiology & Vascular Diseases

Date 1982 Jun 1

PMID 7082498

Citations 10

Authors

E M VAUGHAN WILLIAMS

Affiliations

Soon will be listed here.

Citing Articles

Antiarrhythmic Drugs for Atrial Fibrillation: Selected Features of Ventricular Repolarization That Facilitate Proarrhythmic Torsades de Pointes and Favor Inpatient Initiation.

Reiffel J J Innov Card Rhythm Manag. 2021; 12(7):4600-4605.

PMID: 34327046 PMC: 8313184. DOI: 10.19102/icrm.2021.120704.

Assessing SSRIs' effects on fetal cardiomyocytes utilizing placenta-fetus model.

Arumugasaamy N, Hurley-Novatny A, Lembong J, Kim P, Fisher J Acta Biomater. 2019; 99:258-268.

PMID: 31536839 PMC: 6851498. DOI: 10.1016/j.actbio.2019.09.019.

QT interval as a cardiac risk factor in a middle aged population.

Karjalainen J, Reunanen A, Ristola P, Viitasalo M Heart. 1997; 77(6):543-8.

PMID: 9227299 PMC: 484798. DOI: 10.1136/hrt.77.6.543.

Drug-induced torsade de pointes. Incidence, management and prevention.

Faber T, Zehender M, Just H Drug Saf. 1994; 11(6):463-76.

PMID: 7727055 DOI: 10.2165/00002018-199411060-00007.

Acute effects of amiodarone upon the canine sinus node and atrioventricular junctional region.

Gloor H, Urthaler F, James T J Clin Invest. 1983; 71(5):1457-66.

PMID: 6853721 PMC: 437010. DOI: 10.1172/jci110899.

References

Charlier R, Delaunois G, BAUTHIER J, DELTOUR G . [Research on the benzofuran series. XL. Anti-arrhythmic properties of amiodarone]. Cardiologia (Basel). 1969; 54(2):83-90. View

Singh B, VAUGHAN WILLIAMS E . The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. Br J Pharmacol. 1970; 39(4):657-67. PMC: 1702721. DOI: 10.1111/j.1476-5381.1970.tb09891.x. View

Charlier R . Cardiac actions in the dog of a new antagonist of adrenergic excitation which does not produce competitive blockade of adrenoceptors. Br J Pharmacol. 1970; 39(4):668-74. PMC: 1702729. DOI: 10.1111/j.1476-5381.1970.tb09892.x. View

Ferrero C, Benabderhamane M . [Medical therapy of auricular flutter]. G Ital Cardiol. 1972; 2(1):186. View

Olsson S, Brorson L, VARNAUSKAS E . Class 3 antiarrhythmic action in man. Observations from monophasic action potential recordings and amiodarone treatment. Br Heart J. 1973; 35(12):1255-9. PMC: 458790. DOI: 10.1136/hrt.35.12.1255. View

BACQ Z, BLAKELEY A, Summers R . The effects of amiodarone, an alpha and beta receptor antiagonist, on adrenergic transmission in the cat spleen. Biochem Pharmacol. 1976; 25(10):1195-9. DOI: 10.1016/0006-2952(76)90368-3. View

Schwartz P, Wolf S . QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation. 1978; 57(6):1074-7. DOI: 10.1161/01.cir.57.6.1074. View

Milne J, Camm A, Ward D, Spurrell R . Effect of intravenous propranolol on QT interval. A new method of assessment. Br Heart J. 1980; 43(1):1-6. PMC: 482234. DOI: 10.1136/hrt.43.1.1. View

Williams E, Hassan M, Floras J, Sleight P, Jones J . Adaptation of hypertensives to treatment with cardioselective and non-selective beta-blockers. Absence of correlation between bradycardia and blood pressure control, and reduction in slope of the QT/RR relation. Br Heart J. 1980; 44(5):473-87. PMC: 482432. DOI: 10.1136/hrt.44.5.473. View

10.

Edvardsson N, Olsson S . Effects of acute and chronic beta-receptor blockade on ventricular repolarisation in man. Br Heart J. 1981; 45(6):628-36. PMC: 482575. DOI: 10.1136/hrt.45.6.628. View

11.

McKenna W, Harris L, Perez G, Krikler D, Oakley C, Goodwin J . Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment. Br Heart J. 1981; 46(2):173-8. PMC: 482624. DOI: 10.1136/hrt.46.2.173. View

12.

Tasgal J, Williams E . The effect of prolonged propranolol administration on myocardial transmural capillary density in young rabbits. J Physiol. 1981; 315:353-67. PMC: 1249387. DOI: 10.1113/jphysiol.1981.sp013752. View

13.

Millar J, VAUGHAN WILLIAMS E . Differential actions on rabbit nodal, atrial, Purkinje cell and ventricular potentials of melperone, a bradycardic agent delaying repolarization: effects of hypoxia. Br J Pharmacol. 1982; 75(1):109-21. PMC: 2071450. DOI: 10.1111/j.1476-5381.1982.tb08763.x. View

14.

Sekiya A, VAUGHANWILLIAMS E . A COMPARISON OF THE ANTIFIBRILLATORY ACTIONS AND EFFECTS ON INTRACELLULAR CARDIAC POTENTIALS OF PRONETHALOL, DISOPYRAMIDE AND QUINIDINE. Br J Pharmacol Chemother. 1963; 21:473-81. PMC: 1703883. DOI: 10.1111/j.1476-5381.1963.tb02015.x. View

15.

Ward O . A NEW FAMILIAL CARDIAC SYNDROME IN CHILDREN. J Ir Med Assoc. 1964; 54:103-6. View

16.

Romano C, Gemme G, PONGIGLIONE R . [RARE CARDIAC ARRYTHMIAS OF THE PEDIATRIC AGE. II. SYNCOPAL ATTACKS DUE TO PAROXYSMAL VENTRICULAR FIBRILLATION. (PRESENTATION OF 1ST CASE IN ITALIAN PEDIATRIC LITERATURE)]. Clin Pediatr (Bologna). 1963; 45:656-83. View